TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
European researchers conduct 'biggest ever' COVID supercomputer test
A European research consortium said it had carried out the most complex supercomputing experiment ever conducted on the new coronavirus, during a 60-hour simulation aimed at modelling the effect of potential new COVID drugs.
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
A 24-hour rapid coronavirus testing site is seen at Tom Bradley international terminal at LAX airport, as the global outbreak of the coronavirus disease (COVID-19) continues, in Los Angeles, California, United States, on November 23, 2020. (REUTERS/Lucy Nicholson)
A
European research consortium said on Monday it had carried out the most complex supercomputing experiment ever conducted on the new coronavirus, during a 60-hour simulation aimed at modelling the effect of potential new COVID drugs.
The operation, overseen by the European Commission-backed Excalate4Cov platform, harnessed supercomputers of Italy's Cineca computing consortium and energy giant ENI, testing 70 billion molecules and evaluating 1 trillion interactions.
"We reached the new goal of 5 million simulated molecules per second. As a comparison, ours is more than 300 times bigger and 500 times faster than the one carried out in the US last June," said Andrea Beccari, head scientist of the project.
As drugs makers have raced to develop vaccines for COVID-19, researchers have turned to advanced supercomputers to crunch enormous quantities of data on a virus that was unknown a year ago and which has taken more than 1.3 million lives since it emerged in December.
Read also: Crowdsourced virtual supercomputer revs up virus research
The Excalate4Cov platform led by Italy's Dompé Farmaceutici is backed by the European Commission and coordinates supercomputing centers in Italy, Germany and Spain with pharmaceutical companies and research centers, including the University of Louvain, Fraunhofer Institut, Politecnico di Milano and Spallanzani Hospital.
The operation last weekend was carried out on computers operating at 81 Petaflops (one Petaflop is a unit of computing speed equal to one thousand trillion operations a second).
A first phase of the project ended with the identification of a generic osteoporosis drug that researchers hope may also help reduce COVID-19 symptoms, which last month got the go-ahead for human clinical trials by Italy's main medicines regulator.
